DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Entero Healthcare Solutions Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·22 Sept 2026, 6:47 am

Entero Healthcare Solu L

Entero Healthcare Solutions has announced that it will hold an institutional investor meet and conference call. The company has informed the stock exchanges about the schedule for this event, which is a standard procedure for publicly listed firms to communicate with the investment community.

For investors, this meeting is a key opportunity to gain direct insights into the company's future strategy. It allows shareholders and analysts to hear management's perspective on business operations and growth plans, which can help in assessing the company's long-term potential.

Investors should watch for updates on the company's operational outlook and any guidance provided by management during the call. This information will be crucial for understanding the company's direction and evaluating its performance against market expectations.